ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 903,29
0,23%
DAX
17 932,17
-1,10%
Brent Oil
83,885
0,41%
Bitcoin
57 389,26
-1,46%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Inovio Pharmaceuticals Inc New (INO)

  7. Inovio Pharmaceuticals Inc New (INO) Actualités

INO Inovio Pharmaceuticals Inc New

12,05
0,60 (5,24%)
02 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Inovio Pharmaceuticals Inc New INO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,60 5,24% 12,05 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
11,47 11,315 12,3899 11,59 11,45
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202414:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
29/4/202414:00PRNUSINOVIO to Report First Quarter 2024 Financial Results on May..
16/4/202400:39PRNUSINOVIO Announces Pricing of Approximately $36 Million..
26/3/202423:28PRNUSINOVIO to Participate in The Citizens JMP Novel Therapeutics..
06/3/202422:05PRNUSINOVIO Reports Fourth Quarter and Full Year 2023 Financial..
06/3/202413:00PRNUSGeneos Therapeutics to Present New Clinical Data on..
06/3/202412:02IHMARKETNEWSU.S. Stock Futures Gain Ahead of Economic Insights; Oil..
21/2/202414:00PRNUSINOVIO to Report Fourth Quarter and Year-End 2023 Financial..
07/2/202417:46PRNUSINOVIO to Present at the Oppenheimer 34th Annual Healthcare..
02/2/202414:00PRNUSINOVIO Reports Inducement Grant Under Inducement Plan
01/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/1/202422:01EDGAR2Form S-3/A - Registration statement under Securities Act of..
25/1/202422:02EDGAR2Form 8-K - Current report
23/1/202414:00PRNUSINOVIO Announces Effective Date of 1-for-12 Reverse Stock..
22/1/202414:00PRNUSINOVIO to Participate in Virtual Fireside Chat on the..
12/1/202423:27EDGAR2Form 8-K - Current report
04/1/202414:00PRNUSINOVIO and Coherus Announce Clinical Collaboration to..
03/1/202414:00PRNUSINOVIO Plans to Submit a BLA for INO-3107 as a Potential..
28/11/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202322:00EDGAR2Form PRE 14A - Other preliminary proxy statements
09/11/202322:35EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202322:15EDGAR2Form 8-K - Current report
09/11/202322:05PRNUSINOVIO Reports Third Quarter 2023 Financial Results and..
09/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:01EDGAR2Form 8-K - Current report
01/11/202313:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
26/10/202314:00PRNUSINOVIO to Report Third Quarter 2023 Financial Results on..
10/10/202322:00EDGAR2Form 8-K - Current report
10/10/202316:51DJNInovio Shares Rise 8% After FDA Feedback for INO-3107
10/10/202314:00PRNUSINOVIO Receives FDA Feedback that Data from Completed Phase..
28/9/202301:39PRNUSGeneos Therapeutics Closes its Series A3 Financing With..
07/9/202314:00PRNUSINOVIO Announces U.S. FDA Breakthrough Therapy Designation..
29/8/202314:00PRNUSINOVIO to Present at the H.C. Wainwright 25th Annual Global..
09/8/202322:23EDGAR2Form 8-K - Current report
09/8/202322:05PRNUSINOVIO Announces Second Quarter 2023 Financial Results and..
09/8/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202314:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
01/8/202303:43EDGAR2Form 8-K - Current report
26/7/202315:32PRNUSINOVIO to Report Second Quarter 2023 Financial Results on..
07/7/202322:35EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
03/7/202323:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/6/202322:10GLOBEINOVIO Announces Notice of Pendency and Proposed Settlement..
01/6/202314:00PRNUSINOVIO Reports Inducement Grants Under Inducement Plan
25/5/202314:00PRNUSINOVIO to Present at the 2023 Jefferies Healthcare..
23/5/202322:13PRNUSINOVIO Announces Orphan Drug Designation for INO-3107 for..
10/5/202322:05PRNUSINOVIO Reports First Quarter 2023 Financial Results and..
08/5/202314:00PRNUSNew Data from Phase 1/2 Trial of INO-3107 for the Treatment..
05/5/202314:00PRNUSINOVIO to Present at the 2023 RBC Capital Markets Global..

Dernières Valeurs Consultées

NASDAQ
INO
Inovio Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés